The fusion partners include CD74, SLC34A2, FIG, TPM3, SLC12A2, CCDC6, and SDC4, while CD74-ROS1 fusion is the most prevalent phenotype in NSCLC (92, 93). Here, SLC34A2 is linked to non-small cell lung carcinoma.